JP2023518931A5 - - Google Patents
Info
- Publication number
- JP2023518931A5 JP2023518931A5 JP2022555957A JP2022555957A JP2023518931A5 JP 2023518931 A5 JP2023518931 A5 JP 2023518931A5 JP 2022555957 A JP2022555957 A JP 2022555957A JP 2022555957 A JP2022555957 A JP 2022555957A JP 2023518931 A5 JP2023518931 A5 JP 2023518931A5
- Authority
- JP
- Japan
- Prior art keywords
- immune cell
- cell according
- sequence
- receptor
- interleukin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991497P | 2020-03-18 | 2020-03-18 | |
| US62/991,497 | 2020-03-18 | ||
| US202063004912P | 2020-04-03 | 2020-04-03 | |
| US63/004,912 | 2020-04-03 | ||
| US202063043401P | 2020-06-24 | 2020-06-24 | |
| US63/043,401 | 2020-06-24 | ||
| PCT/IB2021/052292 WO2021186395A1 (en) | 2020-03-18 | 2021-03-18 | Gpc3 car- t cells secreting il-18 and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518931A JP2023518931A (ja) | 2023-05-09 |
| JP2023518931A5 true JP2023518931A5 (https=) | 2024-03-27 |
| JP7778081B2 JP7778081B2 (ja) | 2025-12-01 |
Family
ID=77768034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555957A Active JP7778081B2 (ja) | 2020-03-18 | 2021-03-18 | Ｉｌ－１８を分泌するｇｐｃ３ ｃａｒ－ｔ細胞、並びにそれを作製する方法及び使用する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230151113A1 (https=) |
| EP (1) | EP4121517A4 (https=) |
| JP (1) | JP7778081B2 (https=) |
| KR (2) | KR20220155589A (https=) |
| CN (1) | CN115461449A (https=) |
| AU (1) | AU2021239060A1 (https=) |
| CA (1) | CA3176125A1 (https=) |
| WO (1) | WO2021186395A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024541076A (ja) * | 2021-11-09 | 2024-11-06 | ヤンセン バイオテツク，インコーポレーテツド | Ｔ細胞受容体リガンドを特定するためのマイクロ流体共カプセル化デバイス、システム、及び方法 |
| WO2025183436A1 (ko) * | 2024-02-27 | 2025-09-04 | (주)이노베이션바이오 | Gpc3을 표적으로 하는 키메릭 항원 수용체 및 cd276을 표적으로 하는 키메릭 항원 수용체를 발현하는 면역 이펙터 세포 및 이의 용도 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2009000647A1 (es) * | 2008-04-04 | 2010-06-04 | Chugai Pharmaceutical Co Ltd | Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto. |
| US20150329640A1 (en) * | 2012-12-20 | 2015-11-19 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
| CN104140974B (zh) * | 2013-05-08 | 2017-09-29 | 科济生物医药（上海）有限公司 | 编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞 |
| JP2017529851A (ja) * | 2014-09-26 | 2017-10-12 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | 養子免疫療法のためのグリピカン−３特異的キメラ抗原レセプター |
| JP7096667B2 (ja) * | 2015-07-01 | 2022-07-06 | 中外製薬株式会社 | Ｇｐｃ３標的治療剤が有効である患者に投与されるｇｐｃ３標的治療剤 |
| JP2019530431A (ja) * | 2016-07-26 | 2019-10-24 | テッサ・セラピューティクス・プライベート・リミテッド | キメラ抗原受容体 |
| MX2019008221A (es) * | 2017-01-10 | 2019-12-09 | Univ Yamaguchi | Anticuerpo anti-gpc3. |
| EP3615574A4 (en) * | 2017-04-26 | 2021-02-24 | Eureka Therapeutics, Inc. | SPECIFIC GLYPICAN 3 RECOGNIZING CONSTRUCTS AND THEIR USE |
| US20220127570A1 (en) * | 2018-05-03 | 2022-04-28 | Cafa Therapeutics Limited | Immune effector cell and use thereof |
| CN110468105B (zh) * | 2018-05-09 | 2024-03-22 | 恺兴生命科技(上海)有限公司 | 表达il-18r结合蛋白的免疫效应细胞 |
| WO2020017479A1 (ja) * | 2018-07-17 | 2020-01-23 | ノイルイミューン・バイオテック株式会社 | 抗ｇｐｃ３一本鎖抗体を含むｃａｒ |
| CN115667500B (zh) * | 2020-03-18 | 2026-02-06 | 优特力克斯有限公司 | Gpc3 car-t细胞组合物及其制备和使用方法 |
-
2021
- 2021-03-18 WO PCT/IB2021/052292 patent/WO2021186395A1/en not_active Ceased
- 2021-03-18 KR KR1020227035621A patent/KR20220155589A/ko not_active Ceased
- 2021-03-18 CA CA3176125A patent/CA3176125A1/en active Pending
- 2021-03-18 KR KR1020257033533A patent/KR20250154516A/ko active Pending
- 2021-03-18 US US17/906,722 patent/US20230151113A1/en active Pending
- 2021-03-18 EP EP21771464.1A patent/EP4121517A4/en active Pending
- 2021-03-18 CN CN202180029131.0A patent/CN115461449A/zh active Pending
- 2021-03-18 JP JP2022555957A patent/JP7778081B2/ja active Active
- 2021-03-18 AU AU2021239060A patent/AU2021239060A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523781A5 (https=) | ||
| JP2021000103A5 (https=) | ||
| JP2019516352A5 (https=) | ||
| HRP20221348T1 (hr) | Kimerni receptori i postupci njihove uporabe | |
| JP2021520788A5 (https=) | ||
| KR102879284B1 (ko) | 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도 | |
| JP2023518930A5 (https=) | ||
| JP2021530233A5 (https=) | ||
| JP2018538339A5 (https=) | ||
| JP2020513839A5 (https=) | ||
| JP2019515661A5 (https=) | ||
| JP2019523301A5 (https=) | ||
| JP2025032091A5 (https=) | ||
| RU2017105160A (ru) | Лечение рака с помощью химерного антигенного рецептора к cd33 | |
| JP2017524367A5 (https=) | ||
| JP2022538425A5 (https=) | ||
| JP2017522879A5 (https=) | ||
| JP2024539506A5 (https=) | ||
| RU2019128921A (ru) | Антитело к il-13ra2 и его применение | |
| RU2017105065A (ru) | Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма | |
| JP2017522880A5 (https=) | ||
| RU2017105161A (ru) | Лечение рака с использованием химерного антигенного рецептора cll-1 | |
| JP2018527014A5 (https=) | ||
| JP2024517027A5 (https=) | ||
| JP2025513427A5 (https=) |